Remedi SeniorCare Holding Corporation, a pharmacy that supplies medication to assisted living facilities across several states, has agreed to pay more than $5.3 million after two former employees told the government it billed Medicare and Medicaid for drugs that no valid prescription ever authorized. The settlement resolves civil allegations only; the Justice Department states there has been no determination that the pharmacy actually broke the law. What the case describes, regardless of how it resolves financially, is six years of medications reaching nursing and assisted living residents on paperwork that was never properly signed off. A long-term care pharmacy sits between a resident’s doctor and the medication cart, and the entire arrangement depends on a prescription that actually traces back to a clinician who reviewed the patient.
A Civil Settlement, Not a Finding of Wrongdoing
Remedi, headquartered in Towson, Maryland, agreed to pay over $5.3 million to the United States to resolve allegations that it violated the False Claims Act, according to the Justice Department’s announcement. The case was handled jointly by the Civil Division’s Commercial Litigation Branch and the U.S. Attorney’s Office for the Southern District of Ohio, where the underlying whistleblower case was filed. The Justice Department is explicit about what the payment does and does not establish: “the claims resolved by the settlement are allegations only,” the release states, “and there has been no determination of liability.”
Free first-hour card: After a scam call or identity theft, the order of the first steps matters most. Keep the free first-hour action card on hand.
Six Years of Billing for Drugs Without a Valid Prescription
The government alleged that from Jan. 1, 2015 through March 31, 2021, Remedi submitted claims to Medicare and Medicaid for prescription drugs that lacked valid prescriptions, dispensed to residents of assisted living facilities in multiple states. The release does not specify which drugs or how many claims were involved, only that the conduct spanned more than six years before it was addressed through this settlement. A prescription drug billed to a federal health program is supposed to trace back to a prescriber who actually evaluated the patient and ordered that specific medication; the allegations describe claims submitted without that link in place. In a long-term care setting, that prescription is typically the only checkpoint between a pharmacy’s dispensing system and a resident who may be on a dozen medications at once, unable to independently verify what arrives on the medication cart or why.
The Two Former Employees Who Brought the Case Forward
The settlement resolves a lawsuit filed under the False Claims Act’s whistleblower provisions by Maureen Gearhart and Laura Griffieth, both former Remedi employees. Their case, captioned United States ex rel. Gearhart & Griffieth v. Remedi SeniorCare Holding Corp., et al., No. 1:20cv970, was filed in the Southern District of Ohio. Under the whistleblower provisions, a private party who files this kind of action on the government’s behalf can receive a share of whatever is recovered, and the settlement provides that Gearhart and Griffieth will be paid a portion of Remedi’s payments as they come in.
Medications Reaching Assisted Living Residents Without a Doctor’s Order
Acting Deputy Inspector General for Investigations Miranda L. Bennett of the Department of Health and Human Services Office of Inspector General tied the allegations to resident safety rather than just billing accuracy: “Billing Medicare and Medicaid for drugs dispensed without valid prescriptions puts residents of assisted living facilities at risk and undermines essential safeguards designed to protect patient health and federal health care programs,” Bennett said. A resident in a long-term care setting typically depends on facility staff and a pharmacy to manage which medications arrive and when; a claim submitted without a valid prescription behind it means that safeguard, built specifically to confirm a doctor reviewed the drug and dose, had already failed before the medication reached anyone. The allegations do not describe a single bad prescription slipping through — they describe a pattern running from 2015 through 2021, which is the span the settlement is built to close out.
Paying $5.3 Million Over Time, Based on Ability to Pay
Remedi’s payment terms reflect a company that negotiated based on financial capacity rather than the full scale of the alleged claims: the settlement is based on Remedi’s ability to pay and will be made over time rather than as a lump sum. U.S. Attorney Dominick S. Gerace II for the Southern District of Ohio framed the resolution as routine enforcement rather than an exceptional case: “Billing Medicare and Medicaid for prescription drugs without a valid prescription is unlawful and can present serious risks,” Gerace said. “As evidenced by this settlement, my Office will enforce the FCA to hold responsible those who improperly bill federal programs.” The resolution also involved HHS-OIG and the Ohio Attorney General’s Office, both of which assisted in the underlying investigation. Assistant Attorney General Brett A. Shumate of the Civil Division added that the settlement is meant to protect the population the pharmacy served, not just recover money: “When pharmacies dispense drugs without valid prescriptions, they undermine both patient safety and the integrity of vital federal healthcare programs,” Shumate said. “Today’s resolution demonstrates the Department’s commitment to protecting vulnerable populations and holding accountable pharmacies that fail to comply with their obligations under the False Claims Act.”
Prescriptions Billed Without a Doctor’s Order
A settlement built on prescriptions nobody’s doctor actually authorized is a reminder that a family member’s Medicare or Medicaid number can generate charges no one at the kitchen table approved, and that an Explanation of Benefits full of unfamiliar drug names is worth reading line by line. Catching that early takes the same ordered first-hour habits as any other case of a benefit used without permission.
The Senior Fraud Defense & First-Hour Recovery Kit is a 9-page kit built around the first-hour recovery plan and the free credit-freeze steps.
Open the first-hour recovery plan and the credit-freeze steps in The Senior Fraud Defense & First-Hour Recovery Kit.
This article was researched and drafted with the assistance of AI and reviewed by an editor.
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
